Fluticasone Propionate Spray, Metered
Product Images NDC 73581-510

Product Visual Gallery

This gallery contains 24 technical images submitted to the FDA as part of the official labeling for Fluticasone Propionate (NDC 73581-510). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Yyba Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fluticasone Auro Label (Screenshot 2026 06 01 113346)

Label for FLUTICASONE PROPIONATE 50 mcg per spray, non-drowsy allergy relief nasal spray in a 144 metered spray bottle (0.62 fl oz / 18.2 ml). Distributed by Wellspring, featuring warnings and usage instructions such as for children 4 to 11 years old, storage conditions, and directions. Also notes full prescription strength and 24-hour allergy symptom relief.*

FDA Label Image

Package Label.principal Display Panel (50 mcg per spray (120 Metered Sprays)

FLUTICASONE PROPIONATE 50 mcg/1 meter spray nasal spray by YYBA Corp in a 144 metered spray bottle. The label highlights non-drowsy allergy relief for symptoms including nasal congestion, watery eyes, itchy nose, runny nose, and sneezing. It provides full prescription strength with 24-hour relief. The packaging includes the Welmate logo and a barcode.*

FDA Label Image

Fg (F)

FDA Label Image

F4 (F4)

An instructional illustration showing a metered nasal spray nozzle positioned below an eye with a cross mark above it, indicating that the spray should not be directed into the eye.*

FDA Label Image

Ff (F Image)

A text panel categorizing symptoms and triggers for nasal and eye allergies. It lists nasal symptoms such as congestion, runny nose, sneezing, and itchy nose, eye symptoms including itchy and watery eyes, and allergens divided into outdoor (weed pollen, grass pollen, tree pollen, mold spores), animal (cats, dogs), and indoor allergens (dust, dust mites, mold).*

FDA Label Image

Im1 (Image1)

Illustration showing a stylized purple nose centered between the text '1x' on both the left and right sides, likely indicating doses or application instructions related to nasal use.*

FDA Label Image

I10 (Image10)

Illustration showing a hand holding a metered nasal spray bottle labeled Fluticasone Propionate Nasal Spray, USP. The image depicts the recommended shaking motion with curved arrows around the bottle.*

FDA Label Image

I11 (Image11)

An instructional line drawing showing how to open the cap of a Fluticasone Propionate Nasal Spray bottle. One hand holds the spray bottle labeled with the product name, while the other hand removes the cap from the spray nozzle.*

FDA Label Image

I12 (Image12)

An instructional illustration showing a person using a metered nasal spray, pointing the nozzle towards the nose and pressing the pump to release the spray.*

FDA Label Image

I13 (Image13)

An instructional illustration showing a person using both hands to apply pressure on their nasal area, likely demonstrating a nasal spray usage technique. The person is viewed from the front with closed eyes, focusing on the nose area.*

FDA Label Image

I14 (Image14)

An instructional illustration depicting a person administering a nasal spray. The person holds the spray bottle with one hand, with arrows indicating the direction of the spray nozzle toward the nostril, while the other hand pinches the opposite nostril closed, suggesting steps for proper nasal spray use.*

FDA Label Image

I15 (Image15)

An instructional illustration showing a close-up of a nasal spray actuation tip, labeled "Tip." The image highlights the spray tip portion of a metered nasal spray device for fluticasone propionate.*

FDA Label Image

I16 (Image16)

An instructional illustration showing a nasal spray bottle nozzle positioned near a stylized outline of a human nose, demonstrating the proper angle for nasal spray administration.*

FDA Label Image

I17 (Image17)

An instructional line drawing showing how to use the FLUTICASONE PROPIONATE nasal spray. The image depicts a person holding the spray bottle near the nostril with one hand, while using the other hand to close the opposite nostril. Two arrows indicate the direction of use.*

FDA Label Image

Im2 (Image2)

An instructional illustration showing a stylized nose with '2x' on both sides, likely indicating two sprays per nostril for a nasal spray product.*

FDA Label Image

3 (Image3)

Illustration showing a nasal spray bottle spraying mist diagonally downward, with an eye symbol crossed out above, indicating to avoid spraying the product into the eyes.*

FDA Label Image

I4 (Image4)

FDA Label Image

I5 (Image5)

An instructional diagram showing the correct orientation of a nasal spray bottle. The image includes black silhouette illustrations of the nasal spray bottle and a cap, with arrows indicating the directions to place or remove the cap from the bottle.*

FDA Label Image

I6 (Image6)

An instructional illustration showing a spray nozzle being attached to or aligned with a bottle or container, indicating preparation for use of the nasal spray product.*

FDA Label Image

I7 (Image7)

An instructional diagram showing step 3 of using a nasal spray. The image depicts a silhouette of a metered nasal spray bottle with an arrow pointing downward, indicating a step to press or activate the spray nozzle.*

FDA Label Image

I8 (Image8)

Chemical structure diagram representing the molecular composition of fluticasone propionate, the active ingredient in FLUTICASONE PROPIONATE nasal spray. The diagram shows the distinct ring formations and bonding typical of this corticosteroid compound.*

FDA Label Image

I9 (Image9)

An instructional diagram showing a person using a nasal spray. The illustration depicts the correct technique for administering the spray into the nostril with the head positioned straight forward.*

FDA Label Image

Q2 (Q2)

An illustration showing the interaction between allergens and a triggered cell, resulting in the release of inflammatory substances. The diagram labels allergens as small black circles, the triggered cell as a central larger circle, and inflammatory substances as smaller gray circles emanating from the cell.*

FDA Label Image

Qa (Qa)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.